Advertisement
US Stocks

Cognex Stock Slides 3.1% as VP Sells $9.3M in Shares

Key Points

CGNX stock fell 3.1% to $63.64 as VP sold $9.3M in shares.

Operating income surged 41% with free cash flow up 77% year-over-year.

Analyst consensus shows 15 buy ratings with Meyka AI grade of B+.

Stock remains up 76.9% YTD despite insider selling pressure.

Be the first to rate this article

Cognex Corporation (NASDAQ: CGNX) shares dropped 3.1% to close at $63.64 on May 13, 2026, following significant insider selling activity. Vice President Laura Ann Macdonald sold approximately $9.3 million in CGNX stock across two transactions on May 11-12, reducing her stake by nearly 95%. Despite the pullback, the machine vision leader maintains strong analyst support with 15 buy ratings versus just 2 holds. The stock remains up 76.9% year-to-date, reflecting robust demand for automation and AI-powered inspection systems across manufacturing sectors.

Advertisement

CGNX Stock Price Action and Insider Selling

Cognex Corporation shares retreated from intraday highs as insider activity weighed on sentiment. VP Macdonald executed two separate sales, first selling 98,122 shares at $66.80 on May 11, then offloading 41,600 additional shares at $65.56 on May 12. The combined $9.3 million in sales represents a 94.91% reduction in her direct ownership, leaving her with just 5,258 shares valued at approximately $344,714.

The selling pressure pushed CGNX stock down from its $66.41 intraday high to close near session lows. Trading volume surged to 2.75 million shares, 23.8% above the 30-day average, signaling heightened investor attention. Despite the one-day decline, CGNX remains well above its 50-day moving average of $53.48 and significantly higher than its 200-day average of $45.23, indicating sustained uptrend momentum.

Machine Vision Demand Drives Long-Term Growth

Cognex dominates the machine vision sector, providing critical automation solutions for manufacturers worldwide. The company’s VisionPro software, QuickBuild platform, and deep learning vision tools enable factories to inspect everything from smartphones to pharmaceuticals with precision and speed. Revenue growth of 8.7% year-over-year reflects steady demand across consumer electronics, automotive, and food and beverage industries.

Operating income surged 41.3% in the latest period, demonstrating strong operational leverage as the company scales. Free cash flow jumped 76.6%, reaching $1.45 per share, providing ample capital for R&D and shareholder returns. Track CGNX on Meyka for real-time updates on cash generation and margin expansion as automation adoption accelerates globally.

Analyst Consensus and Valuation Metrics

Wall Street remains constructive on CGNX stock despite recent weakness. Analyst consensus shows 15 buy ratings, 2 holds, and zero sells, reflecting confidence in the company’s competitive positioning. The consensus rating of 3.0 (on a 1-5 scale) signals moderate bullish sentiment among the 18 analysts covering the stock.

Meyka AI rates CGNX with a grade of B+, suggesting a neutral-to-buy stance. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The stock trades at a 74.9x P/E ratio, elevated relative to the broader market but justified by strong earnings growth and cash generation. These grades are not guaranteed and we are not financial advisors.

Market Sentiment: Trading Activity and Insider Moves

Insider selling by VP Macdonald warrants attention, though it doesn’t necessarily signal bearish conviction. Executives often diversify holdings for personal financial planning rather than reflecting company outlook. The magnitude of the sale—reducing her stake to minimal levels—suggests portfolio rebalancing rather than loss of confidence in CGNX stock fundamentals.

Institutional buying activity provides counterbalance to insider sales. Wesbanco Bank Inc. recently acquired 19,000 shares valued at $684,000, adding to CGNX positions. The stock’s technical setup remains constructive with RSI at 66.1, MACD positive, and ADX at 34.7 indicating a strong uptrend, though overbought conditions warrant caution near-term.

Advertisement

Final Thoughts

Cognex’s 3.1% pullback represents normal profit-taking, not fundamental weakness. The machine vision leader benefits from strong automation trends with 41% operating income growth and 77% free cash flow surge. Analyst consensus remains bullish with 15 buy ratings. While the 74.9x P/E multiple is elevated, the company’s market leadership, strong cash generation, and expanding margins justify premium valuation. Investors should view dips as buying opportunities ahead of July 29 earnings.

FAQs

Why did CGNX stock fall 3.1% on May 13?

VP Laura Macdonald sold $9.3 million in shares, reducing her stake by 95%. Insider selling triggered profit-taking, though analyst consensus remains bullish with 15 buy ratings supporting long-term outlook.

What is Cognex Corporation’s main business?

Cognex provides machine vision products and software automating manufacturing and distribution. Solutions inspect and identify products across consumer electronics, automotive, and food industries globally.

Is CGNX stock a good buy at current levels?

Meyka AI rates CGNX as B+ with neutral-to-buy recommendation. Premium 74.9x P/E valuation justified by 41% operating income growth and 77% free cash flow expansion. Analyst consensus: 15 buys versus 2 holds.

When is Cognex’s next earnings announcement?

Cognex reports earnings July 29, 2026 at 4:00 PM ET. Monitor guidance on automation demand, margin trends, and cash flow generation for growth trajectory insights.

What are CGNX stock’s key technical levels?

CGNX closed at $63.64 with 50-day MA at $53.48 and 200-day MA at $45.23. RSI at 66.1 suggests overbought conditions; ADX at 34.7 confirms strong uptrend momentum.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)